Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
$7.64+0.14 (+1.87%)
Close on Nov 13, 2026Market cap $459.08MP/E –Yield –
Oculis cash
Cash and short-term investments held at the end of each period.
Oculis's cash was CHF 61.61M at Jun 30, 2026. For fiscal 2025 it was CHF 81.33M, up 193.5% from the year before. The highest annual figure on record is CHF 81.33M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 81.33M | +193.5% |
| FY2024 | Dec 31, 2024 | CHF 27.71M | -27.7% |
| FY2023 | Dec 31, 2023 | CHF 38.33M | +93.7% |
| FY2022 | Dec 31, 2022 | CHF 19.79M | -57.2% |
| FY2021 | Dec 31, 2021 | CHF 46.28M | +834.5% |
| FY2020 | Dec 31, 2020 | CHF 4.95M | -59.2% |
| FY2019 | Dec 31, 2019 | CHF 12.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | CHF 61.61M | +40.5% |
| Q4 FY2025 | Dec 31, 2025 | CHF 81.33M | +112.2% |
| Q2 FY2025 | Jun 30, 2025 | CHF 64.27M | +53.3% |
| Q4 FY2024 | Dec 31, 2024 | CHF 27.71M | +40.0% |
| Q2 FY2024 | Jun 30, 2024 | CHF 43.85M | -5.2% |
| Q4 FY2023 | Dec 31, 2023 | CHF 38.33M | +674.0% |
| Q2 FY2023 | Jun 30, 2023 | CHF 41.93M | +245.1% |
| Q4 FY2022 | Dec 31, 2022 | CHF 19.79M | – |
| Q4 FY2021 | Dec 31, 2021 | CHF 46.28M | – |
| Q4 FY2020 | Dec 31, 2020 | CHF 4.95M | – |
| Q4 FY2019 | Dec 31, 2019 | CHF 12.15M | – |
See a number that looks wrong?